Main ContentINVESTED
Purpose
This study is looking at whether one type of approved influenza vaccine will reduce cardiovascular and pulmonary problems more than another type of approved influenza vaccine in patients who have had a heart attack or heart failure.
- Principal Investigator: Robert C. Long, MD, PharmD
Who can participate
Those eligible to participate in this study include:
- Adults 18 years of age
- who have had a heart attack or heart failure
- Able to receive the influenza vaccine
For more information
- Theresa Hickey Hutson
University of Mississippi Medical Center
Division of Cardiology
2500 N. State St.
Jackson, MS 39216
(601) 815-8702 - IRB Number: 2017-0215